Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study
| dc.contributor.author | Marateb, Hamid Reza |
| dc.contributor.author | von Cube, Maja |
| dc.contributor.author | Samí, Ramin |
| dc.contributor.author | Javanmard, Shaghayegh Haghjooy |
| dc.contributor.author | Mansourian Gharakozlou, Marjan |
| dc.contributor.author | Amra, Babak |
| dc.contributor.author | Soltaninejad, Forogh |
| dc.contributor.author | Mortazavi, Mojgan |
| dc.contributor.author | Adibi, Peyman |
| dc.contributor.author | Khademi, Nilufar |
| dc.contributor.author | Hosseini, Nastaran Sadat |
| dc.contributor.author | Toghyani, Arash |
| dc.contributor.author | Hassannejad, Razieh |
| dc.contributor.author | Mañanas Villanueva, Miguel Ángel |
| dc.contributor.author | Binder, Harald |
| dc.contributor.author | Wolkewitz, Martin |
| dc.contributor.group | Universitat Politècnica de Catalunya. BIOART - BIOsignal Analysis for Rehabilitation and Therapy |
| dc.contributor.other | Universitat Politècnica de Catalunya. Departament d'Enginyeria de Sistemes, Automàtica i Informàtica Industrial |
| dc.date.accessioned | 2021-09-21T08:29:52Z |
| dc.date.available | 2021-09-21T08:29:52Z |
| dc.date.issued | 2021-12-01 |
| dc.description.abstract | Background: Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-event models are required to account for competing risks (discharge from hospital) and censoring so that active cases can also contribute to the analysis. // Methods: We used the hospital-based open Khorshid COVID Cohort (KCC) study with 630 COVID-19 patients from Isfahan, Iran. Competing risk methods are used to develop a death risk chart based on the following variables, which can simply be measured at hospital admission: sex, age, hypertension, oxygen saturation, and Charlson Comorbidity Index. The area under the receiver operator curve was used to assess accuracy concerning discrimination between patients discharged alive and dead. // Results: Cause-specific hazard regression models show that these baseline variables are associated with both death, and discharge hazards. The risk chart reflects the combined results of the two cause-specific hazard regression models. The proposed risk assessment method had a very good accuracy (AUC¿=¿0.872 [CI 95%: 0.835–0.910]). // Conclusions: This study aims to improve and validate a personalized mortality risk calculator based on hospitalized COVID-19 patients. The risk assessment of patient mortality provides physicians with additional guidance for making tough decisions. |
| dc.description.peerreviewed | Peer Reviewed |
| dc.description.sponsorship | The research leading to these results has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 712949 (TECNIOspring PLUS), and from the Agency for Business Competitiveness of the Government of Catalonia (TECSPR18-1–0017). The TECSPR18-1–0017 project provided the APC. These funders had no role in study design, data collection, analysis, decision to publish, or manuscript preparation. |
| dc.description.version | Postprint (published version) |
| dc.format.extent | 9 p. |
| dc.identifier.citation | Marateb, H.R. [et al.]. Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study. "BMC medical research methodology", 1 Desembre 2021, vol. 21, núm. 146, p. 1-9. |
| dc.identifier.doi | 10.1186/s12874-021-01340-8 |
| dc.identifier.issn | 1471-2288 |
| dc.identifier.other | https://www.researchsquare.com/article/rs-357989/v1 |
| dc.identifier.uri | https://hdl.handle.net/2117/351820 |
| dc.language.iso | eng |
| dc.relation.projectid | info:eu-repo/grantAgreement/ACCIÓ/RIS3CAT/TECSPR18-1-0017 |
| dc.relation.publisherversion | https://bmcmedresmethodol.biomedcentral.com/articles/10.1186/s12874-021-01340-8 |
| dc.rights.access | Open Access |
| dc.rights.licensename | Attribution 4.0 International |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ |
| dc.subject | Àrees temàtiques de la UPC::Ciències de la salut::Medicina |
| dc.subject | Àrees temàtiques de la UPC::Informàtica::Automàtica i control |
| dc.subject.lcsh | Mortality |
| dc.subject.lcsh | Risk assessment |
| dc.subject.lcsh | COVID-19 (Disease) |
| dc.subject.lemac | Mortalitat |
| dc.subject.lemac | Avaluació del risc |
| dc.subject.lemac | COVID-19 (Malaltia) |
| dc.subject.other | Cause-specifc hazard regression |
| dc.subject.other | COVID-19 |
| dc.subject.other | Mortality |
| dc.subject.other | Prognosis |
| dc.subject.other | Risk assessment |
| dc.subject.other | Risk chart |
| dc.title | Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study |
| dc.type | Article |
| dspace.entity.type | Publication |
| local.citation.author | Marateb, H.R.; von Cube, M.; Samí, R.; Javanmard, S.; Mansourian, M.; Amra, B.; Soltaninejad, F.; Mortazavi, M.; Adibi, P.; Khademi, N.; Hosseini, N.; Toghyani, A.; Hassannejad, R.; Mañanas, M.A.; Binder, H.; Wolkewitz, M. |
| local.citation.endingPage | 9 |
| local.citation.number | 146 |
| local.citation.publicationName | BMC medical research methodology |
| local.citation.startingPage | 1 |
| local.citation.volume | 21 |
| local.identifier.drac | 32024407 |
Fitxers
Paquet original
1 - 1 de 1
Carregant...
- Nom:
- absolute_mortality_risk_assessment_covid19_patients.pdf
- Mida:
- 1.25 MB
- Format:
- Adobe Portable Document Format
- Descripció:
- Article



